Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Country / region: Japan Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20083
20091
20105
20132
20152
20161
20172
20184
20194
20201
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting6
Terminated5
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Bristol-Myers Squibb4
Hoffmann-La Roche4
Bayer3
Merck Sharp & Dohme LLC3
Eli Lilly and Company2
Abbott1
BeiGene1
Eisai Limited1
Imunon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular31
Liver Neoplasms10
Neoplasms4
Carcinoma3
Adenocarcinoma1
Digestive System Diseases1
Digestive System Neoplasms1
Liver Diseases1
Neoplasms by Histologic Type1
Neoplasms by Site1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.